Xintela AB (publ) (STO:XINT)

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Stem Cell Therapies	78.00K
Stem Cell Therapies Growth	105.26%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Sweden	78.00K
Sweden Growth	105.26%